Select Bibliography

Filter by any of these (after searching):

Apolo, Andrea

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

Apolo, Andrea B. , Ostrovnaya, Irina , Halabi, Susan ... - - J Natl Cancer Inst - 2013

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90102

External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy.

Apolo, Andrea Borghese , Philips, George , Ostrovnaya, Irina ... - ASCO - J Clin Oncol - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90102

Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation

Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031501